Recombinant human soluble thrombomodulin (rhTM) demonstrates anticoagulation effects superior to heparin for the treatment of disseminated intravascular coagulation (DIC) [12] and improves the outcomes and respiratory functions in patients with sepsis-induced acute respiratory distress syndrome (ARDS) [13]. This evidence concerns the gene THBD and acute respiratory distress syndrome.